Advertisement
New Zealand markets closed
  • NZX 50

    12,619.94
    +47.28 (+0.38%)
     
  • NZD/USD

    0.6160
    -0.0054 (-0.87%)
     
  • NZD/EUR

    0.5605
    -0.0023 (-0.41%)
     
  • ALL ORDS

    8,416.60
    -57.70 (-0.68%)
     
  • ASX 200

    8,150.00
    -55.20 (-0.67%)
     
  • OIL

    74.45
    +0.74 (+1.00%)
     
  • GOLD

    2,673.20
    -6.00 (-0.22%)
     
  • NASDAQ

    20,035.02
    +241.67 (+1.22%)
     
  • FTSE

    8,280.63
    -1.89 (-0.02%)
     
  • Dow Jones

    42,352.75
    +341.16 (+0.81%)
     
  • DAX

    19,120.93
    +105.52 (+0.55%)
     
  • Hang Seng

    22,736.87
    +623.36 (+2.82%)
     
  • NIKKEI 225

    38,635.62
    +83.56 (+0.22%)
     
  • NZD/JPY

    91.5850
    +0.3840 (+0.42%)
     

HealthStream Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

HealthStream (NASDAQ:HSTM) Second Quarter 2024 Results

Key Financial Results

  • Revenue: US$71.6m (up 3.4% from 2Q 2023).

  • Net income: US$4.17m (flat on 2Q 2023).

  • Profit margin: 5.8% (down from 6.0% in 2Q 2023). The decrease in margin was driven by higher expenses.

  • EPS: US$0.14 (up from US$0.14 in 2Q 2023).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

HealthStream EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 1.8%. Earnings per share (EPS) exceeded analyst estimates by 15%.

Looking ahead, revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare Services industry in the US.

Performance of the American Healthcare Services industry.

The company's shares are down 3.4% from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We've done some analysis and you can see our take on HealthStream's balance sheet.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com